"You've got to care to carry this stuff" Community implications from take-home naloxone use: A qualitative study

J Subst Abuse Treat. 2020 Aug:115:108030. doi: 10.1016/j.jsat.2020.108030. Epub 2020 May 11.

Abstract

Background: In New Mexico, drug overdose rates have been among the highest in the nation for the past two decades, with 332 overdose deaths involving opioids in 2017. While interventions aimed at enhancing distribution and uptake of take-home naloxone (THN) have identified people who use opioids as viable candidates, there exists a gap in applying these findings to underserved, ethnic minority women.

Methods: We conducted qualitative interviews with participants recruited from a parent study which recruited 395 women diagnosed with OUD who participated in a two year study (April 2016-May 2018) during which they received opioid overdose education and two free THN kits for their use.

Results: Findings characterize the social dynamics of persistent opioid exposure, accidental overdose, and take home naloxone use to reverse overdose, and we identified three overarching themes: 1) Crisis management and community responsibility; 2) Complex social networks as informal channels for family to family and peer to peer naloxone distribution and education; and 3) Participant preferences and strategies for THN distribution and education.

Conclusions: Participants in the ASAP program demonstrated an unquestionable willingness to distribute naloxone when they had access to it, and the ability to replace it. Further research is warranted to apply these findings in interventional contexts to refine strategies toward prioritizing distribution of THN, enhance training tools and optimize community locations for engagement.

Keywords: Community naloxone use; Naloxone; Opioid overdose reversal; Take home naloxone.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Drug Overdose* / drug therapy
  • Ethnicity
  • Female
  • Humans
  • Minority Groups
  • Naloxone / therapeutic use
  • Narcotic Antagonists / therapeutic use
  • New Mexico
  • Opioid-Related Disorders* / drug therapy

Substances

  • Narcotic Antagonists
  • Naloxone